Arkolith/Insider Trading/NVCR/Form 4

Doyle William F

Executive Chairman, DirectorNovoCure Ltd (NVCR) · full profile →Form 4 · filed Mar 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$933K
Net Open-Market Flow
-$933K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2026Grant(A)200K—$0400K
Mar 3, 2026Sell(S)21K$13.43$286K328K
Mar 3, 2026Sell(S)51K$12.79$647K350K
Mar 3, 2026Grant(A)200K—$0200K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 3, 2026Grant(A)30K—$0289K
Mar 3, 2026Grant(A)258K—$0258K

Transaction Codes

A
Grant / award
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001194459-26-000001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML